Dr Bassil Akra, Vice President, Strategic Business Development, Global Medical Health Services, TÜV SÜD Product Service
Dr Bassil Akra is the vice president of global strategic business development in medical health service of TÜV SÜD Product Service. Dr Akra has long experience in research, development, quality management and regulatory approval of medical devices, combination devices and ATMP products. He is presenting worldwide the requirements in Europe and is involved in the development of several European guidance documents and standards. He is member of the European Clinical Investigation and Evaluation working group and is representing Team NB and NB MED in several European discussions regarding the clinical requirements such as MEDDEV and other Guidance Documents on Innovative Devices. Dr Akra is member of the German MDR Implementation Working Group, the NAKI. He is also member of the new MDR European task forces such as the one on PSUR, SSCP, Clinical Equivalence and sufficient clinical data.
Dr Ashraf Azzabi, MedConnect North Group Member, NIHR CRN NENC Clinical Industry Lead and Consultant Medical Oncologist at the Newcastle upon Tyne NHS Foundation Trust
Dr Azzabi graduated in 1992 and has worked in oncology and cancer research for many years now. He is a Consultant medical oncologist based in the Newcastle upon Tyne Hospitals NHS Foundation Trust and am actively involved in research. Dr Azzabi is also the Clinical Industry Lead for NIHR Clinical Research Network North East and North Cumbria.
Professor Sam Eldabe, MedConnect North Group Lead and Consultant Anaesthetist at South Tees NHS Foundation Trust
Professor Eldabe was appointed Consultant in Pain Medicine at the James Cook University Hospital in 1997 and Professor of Pain Medicine and Anaesthesia at Durham University in 2014. Throughout his career Prof. Eldabe has been an active user and researcher into the role of medical devices in improving patient care. His background in anaesthesia gives him broad exposure to all classes of medical technologies from simple Class I devices to the more complex Class IIB. His work as a chronic pain treatment specialist has afforded him experience in research with various class III active implantable devices.
Dr Teik Goh, GP at the Garth Surgery, Guisborough
Dr Goh works as a GP partner with specialist interest in community geriatric medicine. His fifteen year career started in health economics research at University of Aberdeen, followed by General Practice training and health services research at Newcastle University, and general practice and community geriatric medicine. He is experienced in bringing people together and skilled in facilitating dissemination and implementation of innovations in primary care.
Lindsay Howard, Patient
Lindsay has had a spinal injury since 2006 but has been a T12 complete since 2015. She was at the point where painkillers were no longer useful and pain limited her in every aspect of her life so she was referred to Mr Eldabe for the Senza trial. Lindsay worked full time as a Civil Servant and has a little boy, now 5 years old. Her main passion, apart from her family, is archery. Lindsay took part in the Nevro Senza HF10 trial in 2018-19 and it’s made a big difference to her life.
Professor Amar Rangan, Orthopaedic Surgeon at South Tees NHS Foundation Trust
Amar Rangan is Professor of Orthopaedic Surgery at the Faculty of Medical Sciences, University of Oxford and at The Department of Health Sciences, University of York. Amar maintains his clinical base in Middlesbrough as a specialist shoulder surgeon and leads a programme of clinical effectiveness research and has held several substantial grants, including NIHR grants for multi-centre clinical trials. Amar Chairs the Research Committee for the British Orthopaedic Association and is research lead for orthopaedic surgery at the Royal College of Surgeons of England.
Dr Peter Sargent, Head of Business Development at NIHR Office for Clinical Research Infrastructure (NOCRI)
Dr Peter Sargent leads a team supporting life science companies globally gain access to expertise, facilities and funding from across the NIHR and wider UK health System. His team also works closely with the Department of Health and Social Care, Office for Life Sciences and the Department of International Trade to promote the UK across the globe.
Following obtaining his PhD in Molecular Biology and Biochemistry from King’s College London, Peter has worked with in a variety of In Vitro Diagnostic and Drug Development companies at senior management level, leading R&D and Business Development functions in the development and commercialisation of healthcare products and services. Now working for the NIHR, he utilises his industry experience to support companies in their product development with the aim to bring new technologies and therapies into the NHS.”
Kurt Scott, Grants and Project Delivery Manager at IBEX
Kurt graduated from the University of Sheffield in 2009 with an MEng in Chemical Engineering. Following his degree, he earned a placement on a Knowledge Transfer Partnership working with Durham Business School and Microbac, a north-east water treatment company, to implement project management practice within the company.
Kurt joined IBEX in 2011 and assisted Gary the Founder and CSO in getting the operation up and running. He now works as the Grants and Project Delivery Manager and oversees the day to day operations of the company, including applying for grants and liaising with project stakeholders.